How many countries does LHALALA reach?

The LHALALA brand reports more than 60 countries (2026), up from 31 in 2023, and over 4,000 medical facilities worldwide; a dated partner ledger is still being consolidated by the manufacturer. Named partner markets span Asia-Pacific (Korea, Japan, Hong Kong, Singapore, Thailand, Taiwan, Vietnam, Malaysia, Indonesia, Australia), the Middle East (UAE, Saudi Arabia, Qatar, Kuwait, Bahrain), Europe (Czech Republic) and the Americas (Brazil). LHALALA U.S is its United States operation, now entering the market.

Who manufactures LHALALA?

LHALALA products are manufactured by H2MEDI Co., Ltd., based in Gangnam-gu, Seoul, Korea. H2MEDI was founded in 2018 and reports more than 20 years of skin-treatment expertise.

Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•Global Presence•

Global presence

Present across continents, now entering the United States.

LHALALA is a Korean medical-aesthetic brand manufactured by H2MEDI in Seoul, now entering the United States as LHALALA U.S. The brand reports more than 60 countries and over 4,000 medical facilities. A dated, reproducible partner ledger is still being consolidated by the manufacturer.

The numbers

The footprint, as reported by the brand.

60+countries (2026)
4,000+medical facilities worldwide
2018H2MEDI founded
8countries with distribution agreements

Where LHALALA is present

From Seoul, to clinics around the world.

The brand reports more than 60 countries and over 4,000 medical facilities worldwide. Highlighted below are named LHALALA partner markets across Asia, the Middle East, the Americas, Oceania and Europe, each traced from the brand’s origin in Seoul.

Named LHALALA partner markets
60+ countries in total (brand-reported)

Named partner markets include South Korea (origin), Japan, Hong Kong, Singapore, Thailand, Taiwan, the United Arab Emirates, Vietnam, Qatar, Kuwait, Bahrain, Saudi Arabia, Malaysia, Indonesia, Brazil, the United States, Australia and the Czech Republic — part of a brand-reported footprint of 60+ countries and 4,000+ medical facilities.

Track record

From Seoul to 60+ countries.

2018H2MEDI Co., Ltd. is founded in Gangnam-gu, Seoul, which reports more than 20 years of expertise in skin-treatment procedures.
2023LHALALA products are exported to 31 countries, with distribution agreements across 8 markets and a branch established in Vietnam.
2024H2MEDI signs an exclusive distribution agreement for the United States and the Americas (April 12, 2024).
2026Exports reach more than 60 countries; LHALALA enters the United States as LHALALA U.S.

Reach by region.

Named LHALALA partner markets by region, within a brand-reported footprint of 60+ countries (2026, up from 31 in 2023) and 4,000+ medical facilities. Korea is the home market and brand origin (Seoul); Vietnam hosts a brand branch.

Asia-PacificKorea (origin) · Japan · Hong Kong · Singapore · Thailand · Taiwan · Vietnam · Malaysia · Indonesia · Australia
Middle EastUnited Arab Emirates · Saudi Arabia · Qatar · Kuwait · Bahrain
EuropeCzech Republic
AmericasBrazil · United States, now entering, as LHALALA U.S

On record

Documented, with numbers.

Exclusive U.S. distribution · H2MEDI, 2024
INCUBE · 2 granted Korean patents
QPT™ · granted Korean patent
LHALA JET · FDA-listed, Class I

The manufacturer.

LHALALA is manufactured by H2MEDI Co., Ltd., based in Gangnam-gu, Seoul, Korea. Founded in 2018 and built on over 20 years of skin-treatment expertise, H2MEDI manufactures the line, which is built on the INCUBE, H2sol™ and QPT™ technologies. The underlying patents are held by third-party research institutions, not by H2MEDI. In the United States the line is distributed by Global Trends USA Corp, of Deerfield Beach, Florida, under an exclusive distribution agreement with H2MEDI Co., Ltd. signed on 12 April 2024 and covering the United States, Mexico, Puerto Rico, Hawaii, Alaska and Central and South America excluding Brazil. The mission, in the brand’s own words, is to “minimize discomfort associated with conventional peeling treatments while maximizing treatment efficacy and patient satisfaction.” Read more on the technology page.

A new standard, arriving

Be among the first to bring LHALALA to the U.S.

LHALALA arrives in the U.S. with a documented technology, an international footprint reported by the brand and a single distributor, under an exclusive agreement with the manufacturer signed in April 2024.

Request information